Good Fellow Healthcare Holdings Limited (8143) AI Stock Analysis

• Market Cap: HK$193.90M
• Dividend Yield: N/A
• Average Volume (3M): 491.55K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.22
• Revenue Growth: -30.45%
• EPS Growth: -734.38%
• Country: HK
• Employees: 118
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): >-0.01
• Shares Outstanding: 1,127,299,900
• 10 Day Avg. Volume: 447,466
• 30 Day Avg. Volume: 491,551
• PEG Ratio: 0.10
• Price to Book (P/B): -8.05
• Price to Sales (P/S): 3.25
• P/FCF Ratio: 20.30
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: HK$0.15 ▼(-21.58% Downside)

The score is primarily constrained by very weak financial performance (declining revenue, deep losses, negative equity and leverage risk) and a loss-making valuation profile (negative P/E with no dividend data). Technicals are only modestly supportive, with oversold signals offset by a bearish position versus key short-to-mid-term moving averages.

Positive Factors

Positive operating cash flow

Sustained positive operating cash flow indicates the core distribution and services business can convert sales into cash, supporting day-to-day working capital, supplier payments and selective investment. Over 2–6 months this provides breathing room for restructuring and reduces immediate liquidity pressure despite accounting losses.

High gross profit margin

A gross margin near 52% suggests meaningful pricing power or favorable product mix in medical devices and supplements. This margin base can sustain operating leverage benefits as revenue stabilizes, enabling margin recovery if SG&A is controlled and helping long-term profitability restoration once top-line pressures ease.

Diversified healthcare revenue streams

A multi-stream model—distribution of devices, supplements and institutional partnerships—creates durable revenue channels and lowers single-customer concentration risk. Structural demographic tailwinds (aging populations, rising health awareness) support sustained demand over months, aiding recovery if execution and channel relationships hold.

Negative Factors

Sharp revenue decline

A ~31% revenue drop materially weakens operating leverage, strains fixed-cost coverage and reduces cash available for critical investments. If this trend persists for several quarters it can erode distribution relationships, market share and bargaining power with suppliers, making a durable recovery more difficult without strategic action.

Severely negative profitability

Deep net losses and negative operating margins indicate core operations are not self-sustaining. Over 2–6 months this limits retained earnings and reinvestment, forces reliance on external financing, and raises the bar for operational fixes. Persistent negative profitability undermines confidence in long-term business viability.

Negative shareholders' equity and leverage risk

Negative equity signals solvency pressure and highlights capital structure weakness. It constrains borrowing capacity, increases refinancing and covenant risk, and can force dilutive capital raises. Over the medium term this structural balance-sheet strain limits flexibility to fund growth or weather continued operating stress.

Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model

Company Description

Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.

How the Company Makes Money

Good Fellow Healthcare Holdings Limited generates revenue through multiple streams, including the sale of medical equipment and supplies to healthcare institutions and professionals. The company also earns income from healthcare management services, which involve consulting and operational support for healthcare facilities. Additionally, revenue is derived from wellness programs designed to promote health and prevent illness among consumers. Strategic partnerships with healthcare providers and suppliers further enhance the company's market reach and contribute to its earnings, allowing it to leverage synergies and expand its service offerings.

Good Fellow Healthcare Holdings Limited Financial Statement Overview

Summary

Very weak fundamentals: revenue fell -30.73% and profitability is severely negative (net margin -62.82%, negative EBIT/EBITDA). Balance sheet risk is elevated with negative shareholders’ equity and high leverage indicators. Operating cash flow is positive, but free cash flow growth is sharply negative (-116.36%), limiting financial flexibility.

Income Statement

The company has experienced a significant decline in revenue, with a revenue growth rate of -30.73% in the most recent year. Gross profit margin is relatively stable at 51.92%, but the net profit margin is deeply negative at -62.82%, indicating substantial losses. EBIT and EBITDA margins are also negative, reflecting operational challenges.

Balance Sheet

The balance sheet shows a concerning negative stockholders' equity, leading to a negative debt-to-equity ratio of -1.62. Return on equity is alarmingly high at 155.58%, driven by negative equity, indicating financial instability. The equity ratio is negative, suggesting the company is heavily reliant on debt financing.

Cash Flow

The company has managed to generate positive operating cash flow, but free cash flow growth is negative at -116.36%. The operating cash flow to net income ratio is low at 0.16, and free cash flow to net income ratio is close to 1, indicating limited cash flow generation relative to net losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	18.96M	16.12M	38.96M	55.35M	54.24M	53.89M
Gross Profit	8.46M	8.37M	18.67M	27.01M	26.66M	26.45M
EBITDA	-14.23M	1.86M	-10.12M	1.83M	4.38M	-23.55M
Net Income	-18.99M	-10.13M	-17.11M	-5.88M	-12.69M	-30.18M
Balance Sheet
Total Assets	9.83M	9.83M	29.15M	41.70M	60.45M	191.38M
Cash, Cash Equivalents and Short-Term Investments	4.14M	4.14M	3.88M	18.36M	25.15M	44.89M
Total Debt	10.53M	10.53M	12.23M	4.49M	7.36M	29.73M
Total Liabilities	16.59M	16.59M	27.74M	22.32M	34.08M	158.48M
Stockholders Equity	-6.51M	-6.51M	4.36M	22.19M	29.59M	40.23M
Cash Flow
Free Cash Flow	2.58M	2.58M	-15.35M	-3.84M	-24.51M	-21.21M
Operating Cash Flow	2.62M	2.62M	-854.00K	-1.32M	-22.93M	1.25M
Investing Cash Flow	-1.57M	-1.57M	-14.46M	5.74M	2.19M	-24.28M
Financing Cash Flow	1.06M	1.06M	4.36M	-2.75M	-5.61M	4.83M

Good Fellow Healthcare Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.19
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Positive. The current price of 0.19 is above the 20-day moving average (MA) of 0.16, above the 50-day MA of 0.18, and above the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.42 is Neutral, neither overbought nor oversold. The STOCH value of 61.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8143.

Good Fellow Healthcare Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2293	75 Outperform	HK$197.21M	11.19	7.84%	8.00%	-21.50%	-43.25%
8357	61 Neutral	HK$99.22M	-13.47	-10.31%	―	-11.68%	-71.01%
8307	58 Neutral	HK$79.35M	-60.61	-19.93%	―	-2.91%	55.41%
8161	53 Neutral	HK$22.05M	2.46	125.77%	―	-20.81%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
8143	42 Neutral	HK$193.90M	-6.44	-132.60%	―	-30.45%	-734.38%
8437	41 Neutral	HK$17.32M	-0.58	―	―	14.64%	-81.95%